Class information for:
Level 1: PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8425 1185 50.3 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
288 18308 SEROTONIN//5 HT1A RECEPTOR//5 HT1A RECEPTORS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PINDOLOL Author keyword 22 27% 6% 70
2 VILAZODONE Author keyword 20 57% 2% 24
3 NEUROBIOL PSYCHIAT UNIT Address 16 37% 3% 35
4 DOV 216 303 Author keyword 15 88% 1% 7
5 5 HT1A AUTORECEPTOR Author keyword 14 57% 1% 16
6 TRIPLE REUPTAKE INHIBITOR Author keyword 13 61% 1% 14
7 EMD 68843 Author keyword 11 100% 1% 6
8 DORSAL RAPHE NUCLEUS Author keyword 11 13% 7% 78
9 PYRIDO1 2 CPYRIMIDINES Author keyword 9 83% 0% 5
10 YM992 Author keyword 8 100% 0% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PINDOLOL 22 27% 6% 70 Search PINDOLOL Search PINDOLOL
2 VILAZODONE 20 57% 2% 24 Search VILAZODONE Search VILAZODONE
3 DOV 216 303 15 88% 1% 7 Search DOV+216+303 Search DOV+216+303
4 5 HT1A AUTORECEPTOR 14 57% 1% 16 Search 5+HT1A+AUTORECEPTOR Search 5+HT1A+AUTORECEPTOR
5 TRIPLE REUPTAKE INHIBITOR 13 61% 1% 14 Search TRIPLE+REUPTAKE+INHIBITOR Search TRIPLE+REUPTAKE+INHIBITOR
6 EMD 68843 11 100% 1% 6 Search EMD+68843 Search EMD+68843
7 DORSAL RAPHE NUCLEUS 11 13% 7% 78 Search DORSAL+RAPHE+NUCLEUS Search DORSAL+RAPHE+NUCLEUS
8 PYRIDO1 2 CPYRIMIDINES 9 83% 0% 5 Search PYRIDO1+2+CPYRIMIDINES Search PYRIDO1+2+CPYRIMIDINES
9 YM992 8 100% 0% 5 Search YM992 Search YM992
10 WAY 100635 7 16% 3% 38 Search WAY+100635 Search WAY+100635

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PINDOLOL 36 37% 7% 79
2 1 ARYLOXY 3 PIPERIDINYLPROPAN 2 OLS 30 100% 1% 12
3 AUTORECEPTOR BLOCKADE 28 81% 1% 17
4 EXTRACELLULAR 5 HYDROXYTRYPTAMINE 27 39% 5% 54
5 POSTSYNAPTIC 5 HT1A RECEPTORS 24 39% 4% 48
6 SEROTONIN TRANSPORTER AFFINITY 21 90% 1% 9
7 DUAL 5 HT1A RECEPTOR 18 89% 1% 8
8 ANTAGONISM SSRI ACTIVITIES 17 100% 1% 8
9 EXTRACELLULAR 5 HT 16 41% 3% 30
10 DORSAL RAPHE 15 16% 7% 86

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action 2015 1 52 56%
CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION 1994 833 34 41%
Triple reuptake inhibitors: a patent review (2006-2012) 2014 7 27 33%
Serotonin and beyond: therapeutics for major depression 2013 27 54 37%
Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT 2012 19 98 44%
The pharmacology of putative early-onset antidepressant strategies 2003 134 64 38%
Pindolol augmentation of antidepressant therapy 1998 64 9 100%
Vilazodone: A novel antidepressant 2012 6 16 69%
Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? 2012 20 19 32%
Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder 2010 29 119 30%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROBIOL PSYCHIAT UNIT 16 37% 3.0% 35
2 DISCOVERY EARLY CLIN 6 71% 0.4% 5
3 NEUROPHARMACOL NEUROCHEM 3 57% 0.3% 4
4 UP EAD MENRT 3 100% 0.3% 3
5 RECH CROISSY 3 26% 0.8% 9
6 BIOMONITORING SENSORING 3 22% 0.8% 10
7 NEUROCHEM NEUROPHARMACOL 2 13% 1.1% 13
8 G HAM PSYCHIAT INTENS CARE UNIT 1 100% 0.2% 2
9 PSYCHOPHARMACOL EVALUAT UNIT 1 100% 0.2% 2
10 EA 3544 1 20% 0.5% 6

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000225015 DORSAL RAPHE NUCLEUS//NUCLEUS CENTRALIS SUPERIOR//MEDIAN RAPHE NUCLEUS
2 0.0000224632 BUSPIRONE//5 HT1A LIGANDS//TANDOSPIRONE
3 0.0000182453 5 HT1D RECEPTOR//GR127935//5 HT MODULINE
4 0.0000177924 MPPF//F 18ALTANSERIN//F 18MPPF
5 0.0000167084 CONE NEUROSURG//ALPHA METHYL L TRYPTOPHAN//SEROTONIN SYNTHESIS RATE
6 0.0000159107 MOUSE FORCED SWIMMING//FORCED SWIMMING TEST//TAIL SUSPENSION TEST
7 0.0000155902 MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE
8 0.0000136836 VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM
9 0.0000133233 LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM
10 0.0000109924 BAY X 3702//UMR 7521LN2C//SEROTONIN MODULATED ANTICONSOLIDATION PROTEIN